Full Breakdown
Huawei Launches Diabetes Risk Detection Feature in Smartwatches
2/12/2026, 9:10:42 PM
Innovative Diabetes Risk Assessment Technology
Huawei has introduced a groundbreaking feature in its HUAWEI WATCH GT 6 Pro, allowing users to assess their risk of diabetes through non-invasive monitoring. This technology, unveiled at the World Health Expo Dubai 2026, utilizes Photoplethysmography (PPG) to track changes in blood vessel signals over a period of three to 14 days. The watch collects data on users' PPG signals, categorizing their risk into Low, Medium, or High, with recommendations for medical consultation for those in the Medium or High categories.
Global Diabetes Crisis Context
The introduction of this feature comes amid alarming statistics from the International Diabetes Federation (IDF), which reported in 2024 that approximately 589 million adults aged 20 to 79 have diabetes globally, with 43% undiagnosed. In the Middle East and North Africa (MENA) region, the number of adults living with diabetes is projected to rise from 85 million to 163 million by 2050. The UAE specifically has a diabetes prevalence rate of 20.7% among its adult population.
How the Technology Works
The Huawei smartwatch employs existing heart-rate sensors to monitor PPG signals, which can indicate potential diabetes-related issues. This method is designed to identify long-term changes rather than provide direct blood glucose measurements. Dr. Maryam Al Saeed, an endocrinology specialist at Mohammed Bin Rashid University, emphasized that while the watch can signal elevated glucose levels, it is not a diagnostic tool but rather a prompt for further evaluation.
Comparison with Competitors
Unlike competitors such as Apple, Garmin, and Samsung, which have pursued various glucose monitoring technologies without commercial release, Huawei has successfully launched this feature. Apple has filed multiple glucose-related patents, while Garmin and Samsung are still in the research phase. Huawei's approach focuses on wellness rather than clinical diagnostics, potentially avoiding regulatory hurdles associated with medical devices.
Criticism and Limitations
Despite its innovative approach, Huawei's feature has been met with caution. Experts, including Dr. Al Saeed, have clarified that the smartwatch does not replace professional diabetes diagnostics or lab tests. It serves as a warning signal rather than a definitive diagnosis, urging users to seek medical advice if necessary. This distinction is crucial for users to understand the limitations of the technology.
Future Developments
The Diabetes Risk feature is currently available on the HUAWEI WATCH GT 6 Pro and is expected to be rolled out to additional smartwatch models in the future. Huawei's commitment to enhancing health management through wearable technology is evident, as they continue to explore advancements in PPG-based insights for early diabetes detection.
Verbatim Quotes
- “The watch isn’t going to tell them you’re diabetic, but it’s probably going to tell them the glucose is high.” — Dr. Maryam Al Saeed, Endocrinology Specialist
- “Huawei noted that this function is designed to raise awareness about potential diabetes risks and encourage users to seek early medical intervention.” — Huawei Representative
- “It aims to help users recognize potential wellness trends early and seek expert advice in a timely manner.” — Professor Jiguang Wang, Director of the Shanghai Institute of Hypertension
This innovative feature by Huawei represents a significant step towards proactive health management, particularly in the context of the growing global diabetes crisis.
